Cargando…
Cardiovascular Medication Use and Risk of Acute Exacerbation in Patients With Asthma-COPD Overlap (CVACO Study)
PURPOSE: Current clinical guidelines are unclear regarding the association of cardiovascular medication with the risk of acute exacerbation (AE) in patients with asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO). METHODS: We conducted a retrospective cohort study by interrogating the...
Autores principales: | Su, Vincent Yi-Fong, Ko, Szu-Wen, Chang, Yuh-Lih, Chou, Yueh-Ching, Lee, Hsin-Chen, Yang, Kuang-Yao, Chou, Kun-Ta, Hsu, Chia-Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110917/ https://www.ncbi.nlm.nih.gov/pubmed/35557496 http://dx.doi.org/10.4168/aair.2022.14.3.314 |
Ejemplares similares
-
Independent risk factors for death in patients admitted for asthma exacerbation in Taiwan
por: Chang, Yuh-Lih, et al.
Publicado: (2020) -
Mucolytic Agents and Statins Use is Associated with a Lower Risk of Acute Exacerbations in Patients with Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap
por: Su, Vincent Yi-Fong, et al.
Publicado: (2018) -
Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD
por: Su, Vincent Yi-Fong, et al.
Publicado: (2018) -
Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap
por: Su, Vincent Yi-Fong, et al.
Publicado: (2019) -
Correction for: Real-world effectiveness of medications on survival in patients with COPD-heart failure overlap
por: Su, Vincent Yi-Fong, et al.
Publicado: (2019)